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Background: Smartphone technology presents a novel and promising opportunity to extend the reach of
psychotherapeutic interventions by moving selected parts of the therapy into the real-life situations causing distress.
This randomised controlled trial will investigate the effects of a transdiagnostic, Internet-administered cognitive
behavioural (iCBT) self-help program for anxiety, supplemented with a smartphone application. The effect of added
therapist support will also be studied.
Methods/Design: One hundred and fifty participants meeting diagnostic criteria for social anxiety disorder and/or
panic disorder will be evenly randomised to either one of three study groups: 1, smartphone-supplemented iCBT
with therapist support; 2, smartphone-supplemented iCBT without therapist support; or 3, an active waiting list
control group with delayed treatment. Primary outcome measure will be the Generalised Anxiety Disorder 7-item
self-rating scale. Secondary measures include other anxiety, depression and quality of life measures. In addition to
pre- and post-treatment measurements, the study includes two mid-treatment (days 24 and 48) and two follow-up
assessments (12 and 36 months) to assess rapid and long-term effects.
Discussion: To our knowledge, this is the first study to investigate the effectiveness of smartphone-supplemented
iCBT for anxiety disorders. Hence, the findings from this trial will constitute great advancements in the burgeoning
and promising field of smartphone-administered psychological interventions. Limitations are discussed.
Trial registration: Clinicaltrials.gov: NCT01963806
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Research has consistently supported the effectiveness of
cognitive behavioural self-help programs administered
via the Internet (iCBT) [1] for treating depression [2], a
variety of anxiety disorders [3] and many conditions
within the behavioural medicine field, for example, tin-
nitus [4] and irritable bowel syndrome [5]. The addition
of a therapist to guide the patient through the self-help
program has been found to increase effect sizes [6,7] to* Correspondence: per@carlbring.se
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stated.near-equal or even equal to those of traditional, face-
to-face cognitive behavioural therapy (CBT) [8,9]. Guided
iCBT has demonstrated both efficacy and effectiveness
[10], with similar effect sizes seen when implemented in
routine psychiatric care, for example, in treatment of
panic disorder [11,12]. Higher cost-effectiveness than
group psychotherapy has also been demonstrated (for
example, [13]).
Despite their proven effectiveness, current iCBT programs
leave room for improvement. Just as in traditional face-to-
face CBT, psychotherapeutic information (psychoeducation,
teaching of skills, task assignment and more) is conveyed to
the patient (in iCBT, often in the form of reading modules),l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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records or reports progress. In essence, in current iCBT, the
computer replaces the therapy room yet the overall format
remains the same. Hence, just as in traditional CBT [14],
helping the patient translate and implement what has been
learned in the safe therapeutic environment into real-life
remains a challenge.
The increasing everyday usage of smartphones pre-
sents an exciting and promising opportunity to extend
the reach of psychological interventions and thereby
their effectiveness [15]. Smartphone technology, in the
form of tailored applications (apps) may be used as sup-
plementary iCBT components allowing novel features
such as in-context access to psychoeducational material
and automated, tailored messages, reminders and feed-
back, as well as live reporting of behaviours, thoughts
and feelings unbiased by retrospective recall. Smart-
phone technology thus enables the therapist to move
selected parts of the therapy outside of the session and
into the real-life situations associated with distress or
impairment.
The relatively few studies conducted so far indicate
that smartphone-administered interventions are indeed
effective. A recent randomised controlled trial (RCT)
contrasting smartphone- vs. computer-delivered CBT-
style self-help for depression found equal improvements
in the two groups [16]. Encouraging initial results have
also been found in mobile phone-based behavioural in-
terventions aimed at smoking cessation [17], increasing
physical activity [18], among others. Preliminary research
also supports using smartphone applications to collect
valid psychiatric data [19]. Although the initial results are
promising, the question of how to best make effective use
of smartphone applications for improving mental health
remains unanswered. Importantly, we are not aware of
any study so far targeting anxiety disorders. Whether the
addition of therapist support increases effects, as seen in
regular iCBT [6,7], also remains to be investigated. iCBT
smartphone applications are able to give immediate, auto-
mated feedback, which could prove as effective as personal
feedback from a therapist. Further, since these programs
are often designed to be more user-friendly than regular
iCBT programs, low treatment compliance - which is as-
sociated with worst treatment outcomes - may be a lesser
issue, which means there may be less need for a therapist
to encourage compliance. If the results of this trial indi-
cate equal effects regardless of whether therapist sup-
port is added or not, this will have a great impact on
how future smartphone-supplemented iCBT research is
designed. Until equal effects has been demonstrated,
prior research suggests great treatment effects with
added therapist support.
The purpose of the RCT described in this study proto-
col is two-fold: first, to investigate the effectiveness of atransdiagnostic iCBT program supplemented with a smart-
phone application for two common [20,21] anxiety disor-
ders; and second, to directly compare two ways of
delivering this program, either with or without added sup-
port by a therapist. Both mid-treatment, immediate and
long-term outcomes will be measured. Based on prior
research, we hypothesise that the therapist-guided form
will be superior to the unguided form in reducing anxiety
levels, and that both delivery modes will be superior to an
active waiting-list control group.
Methods/Design
Design
This randomised controlled trial has been registered in
the clinicaltrials.gov registry (NCT01963806) and has
received approval from the Region Ethical Review Board
in Stockholm (approval nr: 2013/880-31/5).
Upon inclusion, participants will be randomised by an
independent researcher using an online randomisation
tool to one of three study groups: 1, iCBT supplemented
with a smartphone application and therapist support; 2,
iCBT supplemented with a smartphone application with-
out therapist support; or 3, an active waiting-list control
group. As in most psychotherapeutic interventions, blind-
ing participants to study arm allocation is not possible in
this case. After the two treatment groups have completed
the post measurements, the control group will receive the
same treatment as group 2 for ethical reasons. This also
entails that there will be no control group to compare with
at the follow-up measurements at 12 and 36 months after
treatment. See Figure 1 for study flowchart.
Procedure
The recruitment and screening procedure will be similar
to other recent iCBT studies by our research group
[22,23]. The study will be advertised nationwide in press
and online. Prospective participants will be directed to a
public website (www.actsmart.se) where they will find fur-
ther information on the study and what participation en-
tails. Screening is done online via a dedicated platform and
includes questions on demographics and treatment history,
as well as the self-rating scales that serve as outcome mea-
sures: the 7-item Generalised Anxiety Disorder (GAD-7)
[24], the Liebowitz Social Anxiety Scale (LSAS-SR) [25,26],
Panic Disorder Severity Scale (PDSS-SR) [27,28], the
9-item Patient Health Questionnaire (PHQ-9) [29] and
the Quality of Life Inventory (QOLI) [30]. Diagnostic
interviews using the Structured Clinical Interview for
DSM disorders (research edition) [31] will be conducted
per telephone [32].
The individual pretreatment data collected from the
screening will be reviewed by the research team, led by an
experienced clinical psychologist and psychotherapist. Par-
ticipants meeting inclusion criteria will be randomised to
Figure 1 Study flowchart.
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or be informed that they will receive treatment after a
10-week delay (group 3).
Sample
The study sample will consist of adults (>18 years old)
living in Sweden with sufficient Swedish and daily access
to the Internet by both computer and smartphone. Par-
ticipants must satisfy DSM-IV-TR [33] diagnostic criteria
for either social anxiety disorder (SAD) or panic disorder
(PD), or both. Primary diagnosis will be determined
during the clinical interview, and will be used as a
between-group factor in second-stage analyses. Partici-
pants enrolled in a parallel psychological treatment will
not be included. Ongoing, regular psychoactive medica-
tion will not serve as grounds for exclusion if dosage has
been stable during the last 3 months. Sporadic use of
psychoactive medication (for example, beta blockers) will
be allowed. Should suspicion arise at any point prior to
commencing treatment or during the treatment period
that a participant is suffering from other treatment-
requiring disorders (including psychiatric ones), the par-
ticipant will be encouraged to seek local care.
Participants who do not meet inclusion criteria will be
personally encouraged to seek treatment alternatives bet-
ter suited to their specific needs. Included participants
will be given a unique, anonymous participant number
with which to log in to the dedicated, SSL-encrypted on-
line platform. Single-use login codes sent by SMS to their
registered telephone number will be used to further guar-
antee secure login. All included participants will be asked
to provide written informed consent before commencingtreatment. Participants who drop out during the treatment
period will not be replaced.
Interventions
Treatment modules
All participants will receive the same self-help program,
either with or without therapist support. The core of
the treatment program has been developed and empiric-
ally tested by our research team in numerous studies
stretching over a decade [10]. Previous clinical RCTs
using the same core treatment modules have demon-
strated post-treatment, between-group Cohen’s d effect
sizes in the range of d = 0.79a [34] and 0.98b [35] for
SAD and d = 1.44c [36] and 1.97d [37] for PD when con-
trasted against waiting-list control groups.
In this trial, the treatment program will be divided
into eight modules covering CBT and Acceptance and
Commitment Therapy (ACT) conceptualisations of
anxiety disorders, as well as more specific therapeutic
techniques such as cognitive restructuring, exposure
training, acceptance training, goal-setting according to
values, attention and breathing exercises, and relapse
prevention. All treatment modules will be accessible
from the online platform at once, allowing individual
pacing [38].
Smartphone application
In addition to these modules, the treatment program will
also include a smartphone application tailored for this
specific study. The application is integrated with the ex-
ercises from the treatment modules, which will encour-
age participants to make frequent use of the application
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cation used in this study have been described elsewhere
[39] and are designed to facilitate behaviour change.
Briefly, the purpose of the application is to help the user
remember and keep track of key behaviours, in order to
promote everyday activation. When a behaviour is com-
pleted, the user can register this using the application
and also add a short reflection. Encouraging, automated
feedback is then given. Statistics and summaries of
quantitative (that is, behaviour frequencies) and qualita-
tive data (that is, reflections) can be accessed by both
the user and an assigned therapist. The therapist can
also send short text messages to the participants via an
in-built messaging system. In this study, this messaging
system will be used by the therapists to send tailored,
encouraging messages to the participants in study group 1,
approximately two or three times a week. Participants will
not be able to reply to these messages. As a rule of thumb,
the therapists will devote 15 minutes per participant and
week. Participants in study group 2 will only receive the
automated feedback from the application (Figure 2).
Instruments
With the exception of the clinical interview conducted
at screening via telephone, all measurements will be col-
lected via the dedicated online platform. Previous psy-
chometric research has validated Internet-administration
of self-rating scales for social anxiety, panic attacks,
quality of life, and general depression and anxiety
[40-42]. Established Swedish translations of all instru-
ments will be used. Measurements will be collected from
all participants at screening, immediately and 12 and
36 months after the treatment period. Additionally, mea-
surements with the GAD-7 and PHQ-9 only will be
completed 24 and 48 days into treatment in order to de-
tect rapid treatment effects. All post-treatment measure-
ments will include questions on potential adverse
outcomes ascribable to treatment, as well as onFigure 2 Screenshots of application in simulated use. (a) Choosing a b
behaviour. (c) Statistics of carried-out behaviours. (d) Feedback.significant changes in life situation (for example, di-
vorce) and changes in parallel treatment status (for
example, change in medication dosage or having
commenced a parallel psychological treatment).
Primary outcome
The Generalised Anxiety Disorder 7-item (GAD-7) scale
will serve as a transdiagnostic measure of common anx-
iety symptoms and will constitute the primary outcome
measure. Although designed to measure symptoms cor-
responding to the DSM-IV diagnosis of generalised anx-
iety disorder (GAD), the symptoms assessed by the
GAD-7 should be considered common across all anxiety
disorders (for example, excessive worrying, trouble relaxing
and so on). The seven items of the scales are rated 0 to 3
(‘Not at all’ to ‘Nearly every day’) based on their occurrence
within the last 2 weeks. Further psychometric evaluation
has reported good internal consistency, factor structure and
sensitivity to change following treatment [43].
Secondary outcomes
As this study will include participant with SAD and/or
PD, diagnosis-specific self-rating scales will complement
measurements of generic anxiety symptoms. Participants
will complete the self-rated Liebowitz Social Anxiety Scale
(LSAS-SR) [25,26] and Panic Disorder Severity Scale
(PDSS) [27,28]. Since we expect some co-morbidity be-
tween these two disorders, all participants will answer
both instruments. All participants will also answer the
9-item Patient Health Questionnaire (PHQ-9) [29,44,45]
to measure depressive symptoms, as well as the Quality
of Life Inventory (QOLI) [30,46] to provide measure of
symptom-independent quality of life.
Calculations and analyses
This study aims to detect a moderate-sized, post-
treatment between-group difference (Cohen’s d = 0.5)
with 80% power, which will require 150 participantsehaviour from repertoire. (b) Saving a comment after carrying out a
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analyses contrasting any two groups, there will be 80%
power to detect a d = 0.66 effect size when Bonferroni-
adjusting the P values for the three possible post-hoc
comparisons. When comparing each treatment group
with the control group, we hypothesise effect sizes larger
than d = 0.66 based on previously studies reporting
higher effect sizes for the same core treatment program
compared to a waiting-list control group [34-37].
Since all self-reported data are collected using the on-
line platform, there is no risk of missing data, or loss or
distortion of data. All analyses will be conducted on an
intention-to-treat basis using a mixed models approach
[47]. Power calculations were performed using the pwr
package (http://CRAN.R-project.org/package=pwr) for
the R statistical environment (http://www.r-project.org/;
version 2.15.3).
Discussion
Supplementing iCBT with tailored smartphone applica-
tions is a promising way to expand the reach of this
already effective intervention. This study protocols de-
scribes a RCT designed to answer two questions import-
ant for the future use of smartphone-supplemented
iCBT: is smartphone-complemented iCBT an effective
treatment of social anxiety disorder and panic disorder;
and, will the addition of support from a therapist impact
results? Few studies so far have investigated the effects
of smartphone-supplemented iCBT interventions on
mental health, and no study has examined the effect on
anxiety disorders specifically.
This study is not designed to compare regular iCBT-
only versus smartphone-supplemented iCBT and hence
does not feature a study arm receiving the former treat-
ment alternative. Due to similarities in recruitment pro-
cedure and the core intervention components (that is, the
treatment modules), we will be able to make cautious
comparisons with the effect sizes found in previous re-
search on regular iCBT-only by our research group. How-
ever, future studies featuring a 2 × 2 intervention design
(iCBT treatment modules yes/no × smartphone applica-
tion yes/no) will be necessary to disentangle the specific
effect of each component used in the current study. An-
other limitation to the current study design is that the
control group, for ethical reasons, will receive treatment
in the second stage of the trial, entailing that there will be
no control group during the follow-up period when long-
term effects are studied. Further, blinding participants to
study arm allocation is not feasible in this study.
These limitations notwithstanding, the results of
this trial will constitute important advancements in the
burgeoning field of mobile health interventions, specif-
ically smartphone-supplemented iCBT interventions. If
found to be effective, off-the-shelf available, customisablesmartphone applications could with negligible effort and
costs be integrated into both iCBT self-help programs and
traditional face-to-face CBT, benefiting both patients and
healthcare providers.
Trial status
At time of initial submission, this trial was recruiting. Re-
cruitment was opened in September 2013 and closed in
October 2013 when 150 participants had been included.
Endnotes
aaEffect size calculated on the LSAS-SR scores.
bbEffect size calculated on the LSAS-SR fear/avoidance
scores.
cEffect size calculated on the Body Sensation Ques-
tionnaire scores.
dEffect size calculated on the Body Sensation Ques-
tionnaire scores.
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